ストックスクリーナーアプリを入手
0.2278
0.96%
-0.0022
アフターアワーズ：
.23
0.0022
+0.97%
前日終値:
$0.23
開ける：
$0.243
24時間の取引高:
208.15K
Relative Volume:
0.56
時価総額：
$6.33M
収益：
-
当期純損益:
$-6.07M
株価収益率:
-0.0394
EPS:
-5.78
ネットキャッシュフロー:
$-7.34M
1週間 パフォーマンス:
+5.32%
1か月 パフォーマンス:
-2.02%
6か月 パフォーマンス:
-55.68%
1年 パフォーマンス:
-76.03%
1日の値動き範囲:
$0.225
$0.243
1週間の範囲:
$0.2105
$0.2442
52週間の値動き範囲:
$0.21
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
名前
Adial Pharmaceuticals Inc
セクター
電話
434-422-9800
住所
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
ADIL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.2278 | 6.39M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-14 | 開始されました | Rodman & Renshaw | Buy |
| 2018-10-30 | 開始されました | Maxim Group | Buy |
| 2018-10-11 | 開始されました | Dawson James | Buy |
Adial Pharmaceuticals Inc (ADIL) 最新ニュース
Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - MSN
Treasury Yields: Will Adial Pharmaceuticals Inc benefit from government policyJuly 2025 Macro Moves & Technical Confirmation Alerts - baoquankhu1.vn
Published on: 2026-01-22 22:09:40 - baoquankhu1.vn
Lobbying Update: $10,000 of ADIAL PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative
Returns Recap: Whats the MACD signal for Adial Pharmaceuticals IncJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045 - Sahm
Adial Pharmaceuticals (ADIL) Secures Patent Application for AD04, Aiming for Long-term Protection - GuruFocus
Adial Pharmaceuticals Announces Publication of International Patent Application for Lead Alcohol Use Disorder Therapy AD04 - Quiver Quantitative
Can Adial Pharmaceuticals Inc. stock continue upward trendQuarterly Growth Report & Technical Entry and Exit Tips - Улправда
Is Adial Pharmaceuticals Inc. stock positioned well for digital economy2025 Stock Rankings & Daily Profit Focused Stock Screening - Улправда
Is Adial Pharmaceuticals Inc. stock affected by interest rate hikesJuly 2025 Summary & Fast Exit/Entry Strategy Plans - Улправда
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr. - Investing.com India
Adial Pharmaceuticals announces immediate resignation of board director - TipRanks
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr. By Investing.com - Investing.com South Africa
Adial Pharmaceuticals Announces Board Resignation - TradingView — Track All Markets
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Pullback Watch: Will Adial Pharmaceuticals Inc stock benefit from M A activityWeekly Trade Analysis & Precise Buy Zone Identification - moha.gov.vn
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Decreases By 31.2% - Defense World
AXIM Biotechnologies (OTCMKTS:AXIM) versus Adial Pharmaceuticals (NASDAQ:ADIL) Financial Comparison - Defense World
Will Adial Pharmaceuticals Inc. stock split again soon2025 Macro Impact & Low Volatility Stock Recommendations - Улправда
Published on: 2025-12-20 18:07:08 - Улправда
Is Adial Pharmaceuticals Inc. stock cheap at current valuationMarket Activity Report & Technical Confirmation Alerts - Улправда
Published on: 2025-12-19 03:23:09 - Улправда
Will Adial Pharmaceuticals Inc. stock deliver shareholder valueStop Loss & Reliable Volume Spike Alerts - Улправда
[EFFECT] ADIAL PHARMACEUTICALS, INC. SEC Filing - Stock Titan
Adial Pharmaceuticals Earnings Notes - Trefis
Volume Recap: Why Adial Pharmaceuticals Inc stock could be next big winner2025 Momentum Check & Consistent Return Strategy Ideas - moha.gov.vn
Litchfield Hills Research Weighs in on ADIL FY2025 Earnings - Defense World
Adial Pharmaceuticals Secures $2.86M Through Warrant Agreement - MSN
Adial Pharmaceuticals, Inc. (ADIL) AI-Powered Stock Analysis - Meyka
How Adial Pharmaceuticals Inc. stock benefits from strong dollarMarket Performance Report & Weekly Return Optimization Plans - Newser
Can Adial Pharmaceuticals Inc. stock attract ESG capital inflowsPortfolio Return Summary & Low Risk Investment Opportunities - Newser
Whale Trades: Can Adial Pharmaceuticals Inc. stock continue upward trendPortfolio Update Summary & Low Risk Growth Stock Ideas - moha.gov.vn
Are Smart Investors Making the Right Decision? Adial Pharmaceuticals Inc (ADIL) - Setenews
Adial Pharmaceuticals raises $2.86 million through warrant exercise By Investing.com - Investing.com Nigeria
Adial Pharmaceuticals (ADIL) Announces Warrant Inducement Agreem - GuruFocus
Adial Pharmaceuticals raises $2.86 million through warrant exercise - Investing.com
Adial Pharmaceuticals Enters Warrant Inducement Agreement for $2.86 Million Capital Raise - Quiver Quantitative
Adial Pharmaceuticals (NASDAQ: ADIL) enters $2.86M inducement at $0.31 exercise price - Stock Titan
Is Adial Pharmaceuticals Inc a good long term investmentMoving Average Crossovers & Learn to Pick Stocks in Under 10 Minutes - earlytimes.in
Why Adial Pharmaceuticals Inc. stock could rally in 20252025 Year in Review & Expert Verified Movement Alerts - newser.com
Will Adial Pharmaceuticals Inc. stock deliver strong dividend growthJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com
Why Adial Pharmaceuticals Inc. stock could benefit from AI revolutionProfit Target & Safe Capital Growth Plans - newser.com
What high frequency data says about Adial Pharmaceuticals Inc.Quarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Adial Pharmaceuticals Inc (ADIL) 財務データ
収益
当期純利益
現金流量
EPS
2.09%
0.48%
大文字化:
|
ボリューム (24 時間):